Philip Arlen

Philip Arlen

Company: Precision Biologics

Job title: President & Chief Executive Officer


Neoantigen Based Monoclonal Antibodies in Combination with Checkpoint Inhibitors 2:00 pm

Identifying tumor neoantigens Determining the function of antibodies targeting the neoantigens Justification for combining with checkpoint inhibitorsRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.